Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span
Open accessThe DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
Little is known about the relative importance of monocyte and tissue-resident macrophages in the development of lung fibrosis. We show that specific genetic deletion of monocyte-derived alveolar macrophages after their recruitment to the lung ameliorated lung fibrosis, whereas tissue-resident alveolar macrophages did not contribute to fibrosis. Using transcriptomic profiling of flow-sorted cells, we found that monocyte to alveolar macrophage differentiation unfolds continuously over the course of fibrosis and its resolution. During the fibrotic phase, monocyte-derived alveolar macrophages differ significantly from tissue-resident alveolar macrophages in their expression of profibrotic genes. A population of monocyte-derived alveolar macrophages persisted in the lung for one year after the resolution of fibrosis, where they became increasingly similar to tissue-resident alveolar macrophages. Human homologues of profibrotic genes expressed by mouse monocyte-derived alveolar macrophages during fibrosis were up-regulated in human alveolar macrophages from fibrotic compared with normal lungs. Our findings suggest that selectively targeting alveolar macrophage differentiation within the lung may ameliorate fibrosis without the adverse consequences associated with global monocyte or tissue-resident alveolar macrophage depletion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent studies suggest that the latter effect is at least in part due to the contribution of pro-fibrotic macrophages to the activation of fibroblasts into to myofibroblasts in a process that depends on physical contact (14, 15).”
From Modeling mechanical activation of macrophages during pulmonary fibrogenesis for targeted anti-fibrosis therapy (2024) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Following tissue injury, many resident macrophages die, and the lung parenchyma initiates an innate immune response characterized by the differentiation of bone marrow-derived monocytes to supplement the macrophage pool 61.”
From Nicotinamide phosphoribosyltransferase prompts bleomycin-induced pulmonary fibrosis by driving macrophage M2 polarization in mice (2024) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The pathogenic role of Mo-AMs in lung fibrosis has been largely attributed to their activity in producing a number of pro-fibrotic mediators, such as TGF-β, PDGF-α, osteopontin (OPN), and MMPs1,3,11,13,15,18,28.”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [1]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“depletion of Mo-AMs via several strategies conferred protection from lung fibrosis in multiple mouse models1,3,10,11,13,20”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“Mo-AMs, but not TR-AMs, are responsible for the pro-fibrotic activity of this group of cells1,3,10,13”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [1]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364 · cited 2×
“, 2013), and differential gene expression was assessed using edgeR (Robinson et al., 2010; McCarthy et al., 2012) R/Bioconductor packages.”
MethodMacrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337
McCarthy, D. J., Chen, Y., & Smyth, G. K. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks042 · Cited by 5,195 · cited 2×
“, 2013), and differential gene expression was assessed using edgeR (Robinson et al., 2010; McCarthy et al., 2012) R/Bioconductor packages.”
MethodThe M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689 · cited 1×
“Macrophage polarization refers to distinct sets of inflammatory (M1) or fibrotic (M2) genes that are expressed by macrophages in cell culture that are first induced toward differentiation and then treated with LPS and IFN-γ or IL-4, respectively (Martinez and Gordon, 2014; Murray et al., 2014).”
BackgroundMacrophages in Tissue Repair, Regeneration, and Fibrosis
Wynn, T. A., & Vannella, K. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.015 · Cited by 4,481
Software for Computing and Annotating Genomic Ranges
Lawrence, M., Huber, W., Pagès, H., Aboyoun, P., Carlson, M., Gentleman, R., Morgan, M. T., & Carey, V. J. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003118 · Cited by 4,398 · cited 3×
“…using FastQC, reads were trimmed and aligned to mm10 reference genome using TopHat2, read counts were associated with genes using the GenomicRanges (Lawrence et al., 2013), and differential gene expression was assessed using edgeR (Robinson et al., 2010; McCarthy et al., 2012) R/Bioconductor…”
MethodInfluentialGOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
Eden, E., Navon, R., Steinfeld, I., Lipson, D., & Yakhini, Z. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-48 · Cited by 3,356
Fate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under Homeostasis
Yona, S., Kim, K.-W., Wolf, Y., Mildner, A., Varol, D., Breker, M., Strauss-Ayali, D., Viukov, S., Guilliams, M., Misharin, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.12.001 · Cited by 3,245 · cited 2×
“2387 IntroductIon Van Furth and colleagues suggested an adult monocytic origin of all macrophages, but it is now clear that many tissue-resident macrophages, including alveolar macrophages in the lung, are self-renewing populations that arise from fetal progenitors and require minimal input from circuiting adult monoc…”
BackgroundSelf-citationHashimoto, D., Chow, A., Noizat, C., Teo, P., Beasley, M. B., Leboeuf, M., Becker, C. D., See, P., Price, J., Lucas, D., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.004 · Cited by 2,311 · cited 3×
“Extending the findings from several groups (Guilliams et al., 2013; Hashimoto et al., 2013; van de Laar et al., 2016), we found that TR-AMs were remarkably stable, constituting >95% of alveolar macrophages at 14 mo of age (Fig.”
BackgroundTranscriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
Xue, J., Schmidt, S. V., Sander, J., Draffehn, A., Krebs, W., Quester, I., De Nardo, D., Gohel, T. D., Emde, M., Schmidleithner, L., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.006 · Cited by 2,210 · cited 1×
“This “macrophage polarization” model is based on limited evidence and is conceptually incomplete (Xue et al., 2014; Nahrendorf and Swirski, 2016).”
Background
Cited by
Items 601–700 of 998
An Agent-Based Model of Radiation-Induced Lung Fibrosis
Cogno, N., Bauer, R., & Durante, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213920 · Cited by 17
Tsukuda, T. K., Ohnishi, H., Fujimoto, M., Nakatani, Y., Takamatsu, K., Naka, T., & Yokoyama, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-24011-0 · Cited by 11
Kang, H., Lee, G. K. C., Bienzle, D., Arroyo, L. G., Sears, W., Lillie, B. N., & Beeler‐Marfisi, J. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282738 · Cited by 15
Monoclonal enolase-1 blocking antibody ameliorates pulmonary inflammation and fibrosis
Huang, W., Chuang, C.-F., Huang, Y.-T., Chung, I., Chen, M.-L., Chuang, T., Yang, X., Chou, Y.-Y., Liu, C.-H., Chen, N., et al. (2023) · Respiratory Research · doi:10.1186/s12931-023-02583-3 · Cited by 15
“More specifically, depletion of monocyte-derived alveolar macrophages (Mo-AMs) within an injured lung can lessen the severity of fibrosis [10].”
BackgroundResultSelf-citationIRAK-M Regulates Monocyte Trafficking to the Lungs in Response to Bleomycin Challenge
Reader, B. F., Sethuraman, S., Hay, B. R., Becket, R. V. T., Karpurapu, M., Chung, S., Lee, Y. G., Christman, J. W., & Ballinger, M. N. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900466 · Cited by 14
Fatty acid nitroalkenes inhibit the inflammatory response to bleomycin-mediated lung injury
Wilkinson, M. L., Абрамова, Е. В., Guo, C., Gow, J. G., Murray, A., Koudelka, A., Cechova, V., Freeman, B. Α., & Gow, A. J. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115236 · Cited by 13
HIV Infection Is Associated with Loss of Anti-Inflammatory Alveolar Macrophages
Neff, C. P., Atif, S. M., Logue, E. C., Siebert, J., Görg, C., Lavelle, J. C., Fiorillo, S. P., Twigg, H. L., Campbell, T., Fontenot, A. P., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000361 · Cited by 14
“Frequencies of cells expressing other proposed markers of tissue-resident AM (TR-AM) and monocyte-derived AM (Mo-AM) including CCR2, CD14, CD36, and CD64 (44, 45) were also examined individually but there were no statistically significant differences between HIV-infected and seronegative subjects (Supplemental Figure…”
BackgroundInfluentialKarhadkar, T. R., Pilling, D., & Gomer, R. H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245924 · Cited by 15
Fu, J., Lü, L., Wang, H., Hou, Y., & Dou, H. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.51654 · Cited by 13
“Necrosis of monocyte-derived AMs can alleviate pulmonary fibrosis [66].”
BackgroundCass, S. P., Mekhael, O., Thayaparan, D., McGrath, J. J. C., Revill, S. D., Fantauzzi, M. F., Wang, P., Reihani, A., Hayat, A. I., Stevenson, C. S., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.740330 · Cited by 15
“Moreover, in preclinical pulmonary fibrosis models, aberrant tissue remodelling has been specifically associated with increased Mo-AM (9, 10, 19) and reduced IM1 (8).”
BackgroundTewari, A., Prabagar, M. G., Gibbings, S. L., Rawat, K., & Jakubzick, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.763379 · Cited by 14
Chauvin, P., Morzadec, C., Latour, B. R. D., Llamas‐Gutierrez, F., Paz, D. L., Jouneau, S., & Vernhet, L. (2022) · Innate Immunity · doi:10.1177/17534259221097835 · Cited by 14
“In addition, the selective genetic deletion of alveolar MoDM after their recruitment to the lungs also significantly reduce lung fibrosis in murine models.(14) The possibility that CD163 could be used as a relevant biological marker for IPF progression remains nevertheless to be demonstrated.”
BackgroundNguyen, J., Deering‐Rice, C. E., Armstrong, B. S., Massa, C. B., Reilly, C. A., & Venosa, A. (2022) · Toxicological Sciences · doi:10.1093/toxsci/kfac074 · Cited by 12
Makinde, H. M., Dunn, J. L. M., Gadhvi, G. T., Carns, M. A., Aren, K., Chung, A. H., Muhammad, L. N., Song, J., Cuda, C. M., Dominguez, S. T., et al. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42380 · Cited by 15
Self-citationChen, T., He, X., Zhou, N., Jia-cui, S., Weng, D., & Li, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114253 · Cited by 14
Mechanisms and Effects of Macrophage Polarization and Its Specifics in Pulmonary Environment
Žaloudíková, M. (2023) · Physiological Research · doi:10.33549/physiolres.935058 · Cited by 16
“…including vascular wall cells, immune cells or fibroblasts, and thus participate in processes in lung tissue related to changes in the activity of these cells (including response to the presence of pathogens, inflammatory responses induced by arbitrary stimuli, tissue remodeling, etc.) [8,57-61].”
Multicompartmental analysis of the murine pulmonary immune response by spectral flow cytometry
Chang, M. Y., Brune, J. E., Black, M. C., Altemeier, W. A., & Frevert, C. W. (2023) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00317.2022 · Cited by 16
Molecular Imaging of Fibrosis in Benign Diseases: An Overview of the State of the Art
Zhang, Y., Huang, W., Jiao, H., Song, L., & Kang, L. (2024) · Pharmaceuticals · doi:10.3390/ph17030296 · Cited by 13
“…mediators that promote fibroblast accumulation and ECM deposition, implicating a potential biomarker of inflammation in the profibrotic process [115], and the depletion of circulating monocytes using CCR2-deficient mice has resulted in profound mitigation of pulmonary fibrosis in preclinical…”
BackgroundMacrophage Origin, Metabolic Reprogramming and IL-1β Signaling: Promises and Pitfalls in Lung Cancer
Guilbaud, E., Gautier, E. L., & Yvan‐Charvet, L. (2019) · Cancers · doi:10.3390/cancers11030298 · Cited by 19
“Although oversimplified, this in vitro classification has provided a useful guide for investigating the mechanisms that dictate macrophage switch during lung inflammation or repair [57,58].”
BackgroundUnravelling fibrosis using single-cell transcriptomics
Dobie, R., & Henderson, N. C. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.09.004 · Cited by 14
Toward a Paradigm to Distinguish Distinct Functions of FOXP3+ Regulatory T Cells
Weinberg, S. E., & Singer, B. D. (2021) · ImmunoHorizons · doi:10.4049/immunohorizons.2100046 · Cited by 13
Self-citationThe Aging Microenvironment Shapes Alveolar Macrophage Identity in AgingPreprint
McQuattie-Pimentel, A. C., Ren, Z.-Y., Joshi, N., Watanabe, S., Stoeger, T., Chi, M., Lu, Z.-Y., Sichizya, L., Piseaux, R., Chen, C., et al. (2019) · bioRxiv · doi:10.1101/717033 · Cited by 10
“…chimeras with thoracic shielding were used to assess the origin of pulmonary macrophages (TRAMs vs. Mo-AMs) and were generated in a manner similar to that previously described (Janssen et al., 2011; Janssen et al., 2010), with additional modifications (Misharin et al., 2014; Misharin et al., 2017).”
BackgroundMethodInfluentialSelf-citationGorica, E., Spezzini, J., Papadopoulou, I., Telesca, M., Masciovecchio, V., Moahmmed, S. A., Mengozzi, A., Cheng, H., Atzemian, N., Venanzio, L. D., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02772-y · Cited by 13
Du, X., Zhang, X., Wang, Z., Wang, D., Li, Y., Liu, Z., Miao, Q., Zhang, H., Duan, L., Hu, Y., et al. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00140.2025 · Cited by 15
In vivo CAR-cell therapy: current challenges and emerging therapeutic advances
Yang, Y.-M., Bao, B., Cao, Y.-H., Yao, J., Ding, Y.-F., Hu, Y.-Y., Fan, F., & Zhao, J. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00447-y · Cited by 16
“CAR-M over-activation presents a distinct toxicity profile, centered on risks of chronic tissue damage and fibrosis [133, 134].”
Technical advance: The use of tree shrews as a model of pulmonary fibrosis
Larson‐Casey, J. L., He, C., Che, P., Wang, M., Cai, G., Kim, Y., Hamdaoui, M. E., Grytz, R., Ding, Q., & Carter, A. B. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241323 · Cited by 16
“Recent studies indicate that monocyte-derived macrophages (MDMs) are responsible for dysregulated fibrotic repair [17, 22].”
BackgroundLiu, N., Feng, Y., Liu, H., Wu, W., Liang, Y., Li, P., Wei, Z., Wu, M., Tang, Z.-H., Han, J., et al. (2021) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2021.13.3.479 · Cited by 12
Ma, M., Bao, T., Li, J., Cao, L., Yu, B., Hu, J., Cheng, H., & Tian, Z. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1192370 · Cited by 12
Macklin, M., Thompson, C., Kawano-Dourado, L. B., Ventura, I. B., Weschenfelder, C., Trostchansky, A., Marcadenti, A., & Tighe, R. M. (2023) · Cells · doi:10.3390/cells12182206 · Cited by 13
Liu, X., Zhang, X., Gao, Y., Tian, J., & Zhao, J. (2023) · eFood · doi:10.1002/efd2.119 · Cited by 14
Tarique, A. A., Tuladhar, N., Kelk, D., Begum, N., Lucas, R. M., Luo, L., Stow, J. L., Wainwright, C. E., Bell, S. C., Sly, P. D., et al. (2024) · Cells · doi:10.3390/cells13020166 · Cited by 15
“While MDMs are appropriate cells to study [30], we assess them remote from their usual site of action.”
BackgroundAconitate decarboxylase 1 mediates the acute airway inflammatory response to environmental exposures
Schwab, A. D., Nelson, A. J., Gleason, A., Schanze, O. W., Wyatt, T. A., Shinde, D. D., Xiao, P., Thomas, V. C., Guda, C., Bailey, K. L., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1432334 · Cited by 12
Ahn, S. H., Halgren, K., Grzesiak, G., MacRenaris, K. W., Sue, A. C., Xie, H., Demireva, E. Y., O’Halloran, T. V., & Petroff, M. G. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf054 · Cited by 12
Liu, J., Guan, L., Wang, E., Schuchman, E. H., He, X., & Zeng, M. (2021) · Journal of Applied Toxicology · doi:10.1002/jat.4148 · Cited by 15
Functional Contributions of Antigen Presenting Cells in Chronic Graft-Versus-Host Disease
Hong, C., Jin, R., Dai, X., & Gao, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.614183 · Cited by 17
“Considering of the different kinetics with clinical symptoms observed in patients, the disease occurrence in mouse cGVHD models is often absence or only happens at late stage after BMT.”
BackgroundInfluentialIbrahim, A., Ciullo, A., Li, C., Akhmerov, A., Peck, K. A., Jones-Ungerleider, K. C., Morris, A. A., Marchevsky, A. M., Marbán, E., & Ibrahim, A. G.-E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.733158 · Cited by 12
Proteomics reveals antiviral host response and NETosis during acute COVID-19 in high-risk patients
Bauer, A., Pachl, E., Hellmuth, J. C., Kneidinger, N., Heydarian, M., Frankenberger, M., Stubbe, H. C., Ryffel, B., Petrera, A., Hauck, S. M., et al. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166592 · Cited by 15
“Association of INFG and TNF-associated monocyte polarization and the pro-fibrotic potential of monocyte-derived alveolar macrophages underline the potential of the observed signature to induce long-term remodeling (88,89).”
BackgroundGrytting, V. S., Skuland, T., Ballangby, J., Refsnes, M., Låg, M., Øvrevik, J., & Mariussen, E. (2024) · Toxicology in Vitro · doi:10.1016/j.tiv.2024.105841 · Cited by 13
Garcia, A. M., Allawzi, A. M., Tatman, P. D., Hernandez‐Lagunas, L., Swain, K. E., Mouradian, G. C., Bowler, R. P., Karimpour‐Fard, A., Sucharov, C. C., & Nozik‐Grayck, E. (2018) · Physiological Genomics · doi:10.1152/physiolgenomics.00053.2018 · Cited by 12
“The dysregulated inflammatory response involves a vast expansion of recruited innate immune cells including neutrophils and monocytes/macrophages, which, if unresolved, drives subsequent lung fibrosis (18).”
BackgroundFine-tuning the ubiquitin-proteasome system to treat pulmonary fibrosis
Roque, W., Summer, R. S., & Romero, F. (2018) · Connective Tissue Research · doi:10.1080/03008207.2018.1529174 · Cited by 13
Insights into interstitial lung disease pathogenesis
Vasarmidi, E., Worrell, J. C., Persson, I. M., Yaqub, N., Miądlikowska, E., Barnig, C., Boots, A. W., Reynaert, N. L., & Ocaña, S. C. (2025) · Breathe · doi:10.1183/20734735.0261-2024 · Cited by 15
“In murine models, deleting monocyte-derived macrophages has been shown to reduce fibrosis severity, highlighting their causal role [62].”
Role of cGAS-STING pathway in fibrotic disease
Feng, L., Zhang, F., Cao, J., & Xiong, W. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107971 · Cited by 15
Yan, Y., Kaihou, T., Lecuona, E., Wu, X., Shigemura, M., Sun, H., Kurihara, C., Gao, R., Nunez-Santana, F., Budinger, G. R. S., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.197579 · Cited by 20
“Focusing on MoMs, critical mediators of fibrosis (33), we identified several CLAD-associated alterations (Supporting Data Values).”
Self-citationChemokine-defined macrophage niches establish spatial organization of tumor immunity
Ghosh, S., Li, X., Rawat, K., Dighal, A., Kalinowski, S., Hosseini, R., Kolling, F., Ringelberg, C. S., & Jakubzick, C. (2026) · Nature Immunology · doi:10.1038/s41590-026-02445-2 · Cited by 18
“In our model, the data strongly indicate that IMs are critical for recruiting B and T cells, resulting in TLS/iBALT formation precisely in the regions where these cells are positioned.”
Monocyte and macrophage function in respiratory viral infections
Arish, M., & Sun, J. (2023) · Animal Diseases · doi:10.1186/s44149-023-00095-7 · Cited by 13
Murthy, A., Rodríguez, L. R., Dimopoulos, T. T., Bui, S., Iyer, S., Chavez, K., Tomer, Y., Abraham, V., Cooper, C., Renner, D. M., et al. (2024) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00324.2023 · Cited by 13
Wen, Z., & Ablimit, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-70659-1 · Cited by 12
“In recent years, monocytes and macrophages promote fibrosis 39,40 , which is mainly caused by local inflammation caused by chemokines and cytokines.”
BackgroundCXCL11 reprograms M2-biased macrophage polarization to alleviate pulmonary fibrosis in mice
Kim, J. Y., Cho, D.-W., Choi, J.-Y., Jeong, S., Kang, M., Kim, W., Hong, I., Song, H., Chang, H., Yang, S., et al. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01320-7 · Cited by 13
“Studies by Alexander et al . and McCubbrey et al . suggest that monocyte-derived macrophages, but not tissue-resident macrophages, are primarily responsible for the progression of fibrosis [24, 25].”
Liang, X., Li, Y., Wu, Y., Wu, T., Huang, D., Tang, Z., Cheng, L., Tan, C., Liao, R., Zhao, J., et al. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04266-w · Cited by 12
“However, these cells remain in PF, thereby promoting the development of fibrotic tissue [13].”
Autophagy and Its Association with Macrophages in Clonal Hematopoiesis Leading to Atherosclerosis
Li, S., Zhou, X., Duan, Q., Niu, S., Li, P., Feng, Y., Zhang, Y., Xu, X., Gong, S., & Cao, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073252 · Cited by 11
“For example, alveolar macrophages in the lungs play a crucial role in clearing inhaled pathogens and particulate matter, thereby contributing to pulmonary defense [101,102].”
Aging affects reprogramming of pulmonary capillary endothelial cells after lung injury in male mice
Truchi, M., Gautier‐Isola, M., Savary, G., Scribe, C., Lingampally, A., Cadis, H., Baeri, A., Magnone, V., Girard-Riboulleau, C., Arguel, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62431-4 · Cited by 19
“Fig3B-C) it would be a better approach to verify these findings in spatial transcriptomics The authors were unable to address this point due to the low resolution of the spatial transcriptomic analysis.”
Yang, M. M., Balmert, L. C., Marangoni, R. G., Carns, M. A., Hinchcliff, M., Korman, B. D., & Varga, J. (2021) · Arthritis Care & Research · doi:10.1002/acr.24749 · Cited by 11
Self-citationAchaiah, A., Lyon, P. C., Fraser, E., Saunders, P., Hoyles, R. K., Benamore, R. E., & Ho, L. (2022) · ERJ Open Research · doi:10.1183/23120541.00226-2022 · Cited by 12
“Mechanistically, our findings could be explained by recent experimental evidence suggesting migration of monocytes from bone marrow to injured lung, then differentiating into macrophages with a pro-fibrotic phenotype [30].”
The role of mitochondrial dysfunction in macrophages on SiO2‐induced pulmonary fibrosis: A review
Zhao, J.-H., Li, S., Du, S., & Zhang, Z.-Q. (2023) · Journal of Applied Toxicology · doi:10.1002/jat.4517 · Cited by 11
“Therefore, the newly monocyte-derived AMs are the main macrophages against silica (Misharin et al., 2017; Zhang et al., 2021).”
BackgroundFate-Mapping Macrophages: From Ontogeny to Functions
Ahlback, A., & Gentek, R. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3437-0_2 · Cited by 13
Superiority of systemic bleomycin to intradermal HOCl for the study of interstitial lung disease
Morozan, A., Joy, S., Fujii, U., Fraser, R. S., Watters, K. A., Martin, J. G., & Colmegna, I. (2023) · Scientific Reports · doi:10.1038/s41598-023-47083-y · Cited by 11
“Despite the lack of evidence for pulmonary injury, we characterized macrophage subsets in PBS and HOCl-treated mice, given their role in bleomycin-induced lung injury and fibrosis 37,38 .”
BackgroundInfluentialAntoniou, K. M., Tsitoura, E., Vasarmidi, E., Symvoulakis, E. K., Aidinis, V., Tzilas, V., Τzouvelekis, Α., & Bouros, D. E. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2020.12.007 · Cited by 12
Hult, E. M., Gurczynski, S. J., & Moore, B. B. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00107.2021 · Cited by 10
Kloth, C., Gruben, N., Ochs, M., Knudsen, L., & López-Rodríguez, E. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00176.2018 · Cited by 12
“Interest in the function of immune cells in the alveolar region of the lung, and specifically of alveolar macrophages during development of lung disease, is increasing exponentially nowadays (5, 38, 41).”
BackgroundResultInfluentialC(C)Learing the Role of Chemokines in Pulmonary Fibrosis
He, C., & Carter, A. B. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0017ed · Cited by 11
“Given recent studies demonstrating that monocyte-derived macrophages promote fibrosis progression (7, 13, 14), it is not surprising that exudate macrophages (defined in this article as SiglecF(2) CD11c(1)autofluorescent(1)) were reduced in mice harboring a conditional deletion of CCL12 in AECs.”
BackgroundMultiple Infections and Lung Damage Models Imply Strategies for Containing the COVID-19 PandemicPreprint
Wu, J., & Zha, P. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3544428 · Cited by 11
A no-Wnt situation for alveolar macrophage self-renewal
Suber, T. L., Camiolo, M. J., & Ray, A. (2021) · Immunity · doi:10.1016/j.immuni.2021.05.013 · Cited by 10
Groetzner, S., Harati, M. D., Kasmi, K. C. E., Schloesser, D., Sauer, J., Olbrich, H., Schuler, M. J., Gantner, F., & Heilker, R. (2023) · SLAS DISCOVERY · doi:10.1016/j.slasd.2023.04.002 · Cited by 10
Early ART reduces viral seeding and innate immunity in liver and lungs of SIV-infected macaques
Clain, J. A., Rabezanahary, H., Racine, G., Boutrais, S., Soundaramourty, C., Beauparlant, C. J., Jenabian, M.-A., Droit, A., Ancuța, P., Zghidi‐Abouzid, O., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.167856 · Cited by 12
“Thus, lung fibrosis is associated with the differentiation of monocytes into alveolar macrophages persisting over the life span (31), whereas monocyte-derived macrophages infiltrating inflamed tissue can also acquire TRM markers (TRM-like cells) (32–34).”
BackgroundNeutrophil–lymphocyte ratio in patients with idiopathic pleuroparenchymal fibroelastosis
Suzuki, Y., Kono, M., Hasegawa, H., Hashimoto, D., Yokomura, K., Imokawa, S., Inoue, Y., Hozumi, H., Karayama, M., Furuhashi, K., et al. (2023) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2023-001763 · Cited by 9
Li, M., Yu, W., Liu, Z., & Liu, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115705 · Cited by 10
“During the course of pulmonary fibrosis, alveolar macrophages upregulated both M1 and M2 genes in response to bleomycin without an overwhelming shift in gene expression toward an M1 or M2 phenotype [39].”
BackgroundYang, L., Wei, X., Sun, P., Wang, J., Zhou, X., Zhang, X., Luo, W., Zhou, Y., Zhang, W., Fang, S., et al. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.135540 · Cited by 12
Characterization of Recruited Mononuclear Phagocytes following Corneal Chemical Injury
Lamy, R., Wolf, M., Bispo, C., Clay, S. M., Zheng, S., Wolfreys, F. D., Pan, P., & Chan, M. F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052574 · Cited by 10
Salt-inducible kinase 2 regulates fibrosis during bleomycin-induced lung injury
van Gijsel‐Bonnello, M., Darling, N. J., Tanaka, T., Carmine, S. D., Marchesi, F., Thomson, S. M., Clark, K., Kurowska‐Stolarska, M., McSorley, H. J., Cohen, P., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102644 · Cited by 12
A novel leptin receptor binding peptide tethered-collagen scaffold promotes lung injury repair
Zhuang, Y., Yang, W., Zhang, L., Fan, C., Qiu, L., Zhao, Y., Chen, B., Chen, Y., Shen, H., & Dai, J. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121884 · Cited by 10
VISTA (PD-1H) Is a Crucial Immune Regulator to Limit Pulmonary Fibrosis
Kim, S., Adams, T. S., Hu, Q., Shin, H. J., Chae, G., Lee, S. E., Sharma, L., Kwon, H., Lee, F. Y., Park, H., et al. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2022-0219oc · Cited by 9
Effendi, W. I., & Nagano, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054428 · Cited by 10
The in vitro immunomodulatory effect of multi-walled carbon nanotubes by multilayer analysis
Hautanen, V., Morikka, J., Saarimäki, L. A., Bisenberger, J., Toimela, T., Serra, A., & Greco, D. (2023) · NanoImpact · doi:10.1016/j.impact.2023.100476 · Cited by 10
Zhou, D., Wu, Y., Wang, S., Li, J., & Luan, J. (2020) · Immunity Inflammation and Disease · doi:10.1002/iid3.341 · Cited by 11
“This long‐held view of antifibrotic therapy by directly targeting lung myofibroblasts has been challenged by evidence for a dual role of alveolar macrophages (AMs) in the pathophysiology of PF, either pro‐inflammatory or anti‐inflammatory effects.(37) Fibrotic changes in the lungs are developed from exposure to variou…”
BackgroundGilliaux, G., & Desmecht, D. J.-M. (2022) · Viruses · doi:10.3390/v14010098 · Cited by 9
Kendall, R. L., Ray, J. L., Hamilton, R. F., & Holian, A. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116400 · Cited by 9
Shh regulates M2 microglial polarization and fibrotic scar formation after ischemic stroke
Yang, Q., Jiang, P., Tang, H., Wen, J., Zhou, L., Zhao, Y., Wang, L., Wang, J., & Yang, Q. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105862 · Cited by 11
Tumor cell-derived osteopontin promotes tumor fibrosis indirectly via tumor-associated macrophages
Tan, Y., Yang, Y., Zhang, X., Zhao, L., Wang, X., & Liu, W. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06444-z · Cited by 13
“TGFβ1 is a key pro-fibrotic factor produced by macrophages, but the TAM subsets that promote fibrosis via TGFβ1 vary across different disease settings [8, 35, 36].”
Ye, Y., Nie, H., Nie, H., Zhang, G., Tu, L., Ao, M., Liang, X., Yang, C., Huang, X., Mei, Z., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120089 · Cited by 9
Kim, S., Nouws, J., Ruwisch, J., Woodard, G. A., Cooley, J. C., Khoury, J., Sun, H., Doherty, E. H., Piecychna, M., Manning, E. P., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adr2277 · Cited by 10
Arif, A. A., Huang, Y.-H., Freeman, S. A., Atif, J., Dean, P., Lai, J. C. Y., Blanchet, M., Wiegand, K. C., McNagny, K. M., Underhill, T. M., et al. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0009 · Cited by 9
“These changes are indicative of monocytes differentiating into MoDM—and eventually into AM as they gain higher levels of SiglecF—a process that has been documented previously in BLM- and LPS-mediated inflammation models (18, 29).”
BackgroundMethodInfluentialKaba, S., Kawai, Y., Tanigami, Y., Ohnishi, H., Kita, T., Yoshimatsu, M., Omori, K., & Kishimoto, Y. (2022) · American Journal Of Pathology · doi:10.1016/j.ajpath.2022.02.002 · Cited by 9
Suppression of Allergic Asthma by Loss of Function of Miz1-mediated Th1 Skewing
Do-Umehara, H. C., Chen, C., Zhang, Q., Schleimer, R. P., Budinger, G. R. S., & Liu, J. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2022-0135oc · Cited by 9
Self-citationA Novel MIP-1–Expressing Macrophage Subtype in BAL Fluid from Healthy Volunteers
Reyfman, P. A., Malsin, E. S., Khuder, B., Joshi, N., Gadhvi, G. T., Flozak, A. S., Carns, M. A., Aren, K., Goldberg, I. A., Kim, S.-J., et al. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0123oc · Cited by 9
Self-citationVasse, G. F., Russo, S. L. M. L., Barcaru, A., Oun, A., Dolga, A. M., van Rijn, P., Kwiatkowski, M., Govorukhina, N. I., Bischoff, R., & Melgert, B. N. (2023) · Scientific Reports · doi:10.1038/s41598-023-32715-0 · Cited by 9
Scortegagna, M., Du, Y., Bradley, L. M., Wang, K., Molinolo, A., Ruppin, E., Murad, R., & Ronai, Z. A. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-0258 · Cited by 9
Alveolar macrophages from EVALI patients and e-cigarette users: a story of shifting phenotype
Warren, K. J., Beck, E. M., Callahan, S. J., Helms, M. N., Middleton, E. A., Maddock, S. D., Carr, J. R., Harris, D., Blagev, D., Lanspa, M. J., et al. (2023) · Respiratory Research · doi:10.1186/s12931-023-02455-w · Cited by 13
Wang, S., Zhou, H., Mao, J., Zhang, Y., Qi, Y., Mei, P., Jin, X., Zhang, J., Luo, L., & You, J. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123420 · Cited by 11
Shades of white: new insights into tissue‐resident leukocyte heterogeneity
Psaila, A. M., Vohralik, E. J., & Quinlan, K. G. R. (2021) · FEBS Journal · doi:10.1111/febs.15737 · Cited by 10
The diversity of adult lung epithelial stem cells and their niche in homeostasis and regeneration
Wang, Y., & Tang, N. (2021) · Science China Life Sciences · doi:10.1007/s11427-020-1902-3 · Cited by 10
Zhang, X., Yi, F., & Shi, H. (2021) · Cancer Management and Research · doi:10.2147/cmar.s305223 · Cited by 11
Teitz‐Tennenbaum, S., Viglianti, S. P., Jomma, A., Palone, Q., Andrews, H., Selbmann, K. N., Lahiri, S., Subbotina, N., Walker, N., Perl, A. T., et al. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.11.012 · Cited by 10
Increased L-Selectin on Monocytes Is Linked to the Autoantibody Profile in Systemic Sclerosis
Brezovec, N., Pirkmajer, K. P., Kuret, T., Burja, B., Sodin‐Šemrl, S., Čučnik, S., & Lakota, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042233 · Cited by 9
Herbert, R. A., Janardhan, K. S., Pandiri, A. R., Cesta, M. F., Chen, V., & Miller, R. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-391448-4.00023-x · Cited by 9
“In inflammatory conditions, circulating monocytes arising from the bone marrow also serve as a source of alveolar macrophages (Misharin et al., 2017).”
BackgroundMyeloid- and epithelial-derived RELMα contribute to tissue repair following lung helminth infection
Sveiven, S., Kim, S. Y., Barrientos, V., Li, J., Jennett, J., Asiedu, S. O., Anesko, K., Nordgren, T. M., & Nair, M. G. (2023) · Frontiers in Parasitology · doi:10.3389/fpara.2023.1242866 · Cited by 8
“…markedly alters macrophage populations, causing the recruitment of monocyte-derived alveolar macrophages (Mo-AMs) from the blood that replenish the tissue-resident AM (TR-AM) population, which are originally derived from the fetal liver and yolk sac (Guilliams et al., 2013; Misharin et al., 2017).”
BackgroundSung, E., Park, M. H., Song, S.-J., Alanya, H., Henegariu, O., Liu, J., Erson-Omay, Z., Sime, P. J., & Chae, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1247330 · Cited by 8
Graf, J., Bomb, K., Trautmann-Rodriguez, M., Jarai, B. M., Gill, N. A., Kloxin, A. M., & Fromen, C. A. (2024) · Frontiers in Biomaterials Science · doi:10.3389/fbiom.2024.1399448 · Cited by 11
EGR2 is an epigenomic regulator of phagocytosis and antifungal immunity in alveolar macrophages
Kolostyák, Z., Bojcsuk, D., Baksa, V., Szigeti, Z. M., Bene, K., Czimmerer, Z., Botó, P., Fadel, L., Póliska, S., Halász, L., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.164009 · Cited by 11
“The short time course ensured that the response of AMs was measured and no significant amount of circulating monocyte-derived cells were present in the lung [12] [32].”
BackgroundMonocytes give rise to Langerhans cells that preferentially migrate to lymph nodes at steady state
Raquer-McKay, H. M., Maqueda‐Alfaro, R. A., Saravanan, S., Hornero, R. A., Clausen, B. E., Gottfried‐Blackmore, A., & Idoyaga, J. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2404927121 · Cited by 9
“Current evidence suggests that ontogeny accounts for heterogeneity in the features of some tissue macrophages, but not others ( 17 , 18 , 20 , 63 , 64 ).”
Zhang, J., Wang, T., Wang, Y., Li, Y., Wang, L., Wang, J., Miao, Y., Xu, F., & Yao, Y. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115571 · Cited by 10
Metadata
- Authors
- Misharin, A. V., Morales-Nebreda, L., Reyfman, P. A., Cuda, C. M., Walter, J. M., McQuattie-Pimentel, A. C., Chen, C.-I., Anekalla, K. R., Joshi, N., Williams, K. J. N., Abdala-Valencia, H., Yacoub, T. J., Chi, M., Chiu, S., Gonzalez-Gonzalez, F. J., Gates, K., Lam, A. P., Nicholson, T. T., Homan, P. J., Soberanes, S., Dominguez, S., Morgan, V. K., Saber, R., Shaffer, A., Hinchcliff, M., Marshall, S. A., Bharat, A., Berdnikovs, S., Bhorade, S. M., Bartom, E. T., Morimoto, R. I., Balch, W. E., Sznajder, J. I., Chandel, N. S., Mutlu, G. M., Jain, M., Gottardi, C. J., Singer, B. D., Ridge, K. M., Bagheri, N., Shilatifard, A., Budinger, G. R. S., & Perlman, H.
- Affiliations
- Northwestern University (US)
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 1
- Division of Rheumatology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 2
- Scripps Research Institute (US)
- University of Chicago (US)
- Corresponding author
- Perlman, Harris
- ORCID
- Misharin, Alexander V.
- Reyfman, Paul A.
- Cuda, Carla M.
- Walter, James M.
- McQuattie-Pimentel, Alexandra C.
- Chen, Ching-I
- Anekalla, Kishore R.
- Joshi, Nikita
- Chiu, Stephen
- Gonzalez-Gonzalez, Francisco J.
- Lam, Anna P.
- Nicholson, Trevor T.
- Homan, Philip J.
- Soberanes, Saul
- Dominguez, Salina
- Morgan, Vince K.
- Saber, Rana
- Shaffer, Alexander
- Hinchcliff, Monique
- Marshall, Stacy A.
- Bharat, Ankit
- Berdnikovs, Sergejs
- Bhorade, Sangeeta M.
- Bartom, Elizabeth T.
- Morimoto, Richard I.
- Balch, William E.
- Sznajder, Jacob I.
- Chandel, Navdeep S.
- Mutlu, Gökhan M.
- Jain, Manu
- Gottardi, Cara J.
- Singer, Benjamin D.
- Ridge, Karen M.
- Bagheri, Neda
- Shilatifard, Ali
- Budinger, G.R. Scott
- Perlman, Harris
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2017-07-10
- Volume
- 214
- Issue
- 8
- Pages
- 2387-2404
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC5551573
- OpenAlex
- W2736034593
- Cited by
- 1,133
- References
- 87
- Citations by year
- 2026: 139 · 2025: 131 · 2024: 156 · 2023: 135 · 2022: 136 · 2021: 128 · 2020: 134 · 2019: 81 · 2018: 77 · 2017: 15
- FWCI
- 68.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- NIH (AR064313, HL128867, T32 DK077662, HL125940, AG049665, HL048129, HL071643, HL085534, ES015024, ES025644, HL079190, HL124664, ES013995, AR064546, HL134375)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR061593)
- Scleroderma Foundation
- Department of Defense (PR141319)
- BD Bioscience
- Northwestern University (5T32 HL076139-13)
- American Society for Transplant Surgery Foundation
- Thoracic Surgery Foundation
- Society of University Surgeons
- American Association of Thoracic Surgery
- Parker B. Francis
- Veterans Administration (BX000201)
- Mabel Greene Myers
- National Cancer Institute (P30 CA060553)
- Feinberg School of Medicine
- American Thoracic Society
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- pulmonary fibrosis, alveolar macrophages, monocyte-derived macrophages, tissue-resident macrophages, monocyte-to-macrophage differentiation, fibrosis resolution, gene deletion, gene expression profiling
- MeSH terms
- Animals, Cell Differentiation, Fibrosis, Humans, Lung, Monocytes, Macrophages, Alveolar, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.